Both in Pharmaceuticals
ZOETIS vs Jazz Pharmaceuticals
Over the past year ZTS returned −28.3% and JAZZ returned +70.3%; their daily moves had a correlation of 0.10.
ZTS −28.3% JAZZ +70.3%Growth of $1, one year, split-adjusted
| Metric | ZTS | JAZZ |
|---|---|---|
| Price | $89.20 | $234.66 |
| Market cap | $36.86B | $15.23B |
| Today | +7.48% | +2.14% |
| 1 month | +25.1% | +1.4% |
| 6 months | −19.8% | +2.7% |
| Year to date | −29.1% | +38.0% |
| 1 year | −38.2% | +69.6% |
| Revenue growth (YoY) | −0.2% | +10.4% |
| Gross margin | 72.7% | 91.1% |
| Net margin | 28.0% | −38.9% |
| P/E (TTM) | 14.1× | 74.0× |
| Price / sales | 3.9× | 3.2× |
| Net cash | -$7.37B | -$2.71B |
| Dividend yield | 2.38% | — |
| Volatility (60d) | 32.1% | 31.2% |
| Short % of float | 4.2% | 9.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).